Unknown

Dataset Information

Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation.


ABSTRACT:

Objective

The microbiome is recognized as a new frontier in medicine with connections to a variety of diseases. We aimed to evaluate the association of lipopolysaccharide (LPS), a key pro-inflammatory product of the microbiome, with severity of inflammation, symptoms and radiographic abnormalities of knee osteoarthritis (OA).

Design

LPS was measured using a recombinant Factor C (rFC) assay, carefully optimized for systemic and synovial fluid (SF) analyses. LPS binding protein (LBP) was tested in both serum and SF of 25 patients (31 knees) from the Etarfolatide cohort for association with OA phenotypic outcomes. Models were adjusted for age, gender and body mass index.

Results

Based on LPS spike-and-recovery, both serum and SF dilutions of 0.1% were required to achieve

SUBMITTER: Huang ZY 

PROVIDER: S-EPMC5026878 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature